Beijing Leadman Biochemistry Co Ltd
SZSE:300289
Income Statement
Earnings Waterfall
Beijing Leadman Biochemistry Co Ltd
Revenue
|
448m
CNY
|
Cost of Revenue
|
-205.7m
CNY
|
Gross Profit
|
242.3m
CNY
|
Operating Expenses
|
-245.3m
CNY
|
Operating Income
|
-3m
CNY
|
Other Expenses
|
7.3m
CNY
|
Net Income
|
4.3m
CNY
|
Income Statement
Beijing Leadman Biochemistry Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
342
N/A
|
363
+6%
|
373
+3%
|
537
+44%
|
607
+13%
|
642
+6%
|
682
+6%
|
682
0%
|
660
-3%
|
639
-3%
|
618
-3%
|
533
-14%
|
521
-2%
|
532
+2%
|
538
+1%
|
576
+7%
|
634
+10%
|
663
+5%
|
711
+7%
|
655
-8%
|
600
-8%
|
563
-6%
|
493
-12%
|
515
+4%
|
454
-12%
|
440
-3%
|
478
+9%
|
472
-1%
|
531
+13%
|
541
+2%
|
561
+4%
|
564
+1%
|
640
+13%
|
693
+8%
|
692
0%
|
706
+2%
|
623
-12%
|
559
-10%
|
504
-10%
|
462
-8%
|
448
-3%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(130)
|
(143)
|
(149)
|
(206)
|
(257)
|
(272)
|
(286)
|
(288)
|
(276)
|
(271)
|
(274)
|
(239)
|
(246)
|
(253)
|
(258)
|
(259)
|
(313)
|
(329)
|
(360)
|
(332)
|
(307)
|
(279)
|
(236)
|
(240)
|
(211)
|
(209)
|
(225)
|
(216)
|
(247)
|
(253)
|
(273)
|
(270)
|
(345)
|
(389)
|
(392)
|
(408)
|
(347)
|
(298)
|
(261)
|
(198)
|
(206)
|
|
Gross Profit |
213
N/A
|
220
+4%
|
225
+2%
|
332
+47%
|
350
+5%
|
370
+6%
|
396
+7%
|
394
-1%
|
384
-2%
|
369
-4%
|
345
-7%
|
294
-15%
|
275
-6%
|
280
+2%
|
280
+0%
|
317
+13%
|
322
+1%
|
334
+4%
|
350
+5%
|
323
-8%
|
293
-9%
|
284
-3%
|
257
-10%
|
275
+7%
|
243
-12%
|
231
-5%
|
254
+10%
|
256
+1%
|
284
+11%
|
288
+1%
|
288
+0%
|
294
+2%
|
295
+0%
|
304
+3%
|
299
-1%
|
298
0%
|
275
-8%
|
260
-5%
|
243
-7%
|
264
+8%
|
242
-8%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(103)
|
(114)
|
(125)
|
(160)
|
(172)
|
(172)
|
(184)
|
(181)
|
(169)
|
(181)
|
(184)
|
(192)
|
(177)
|
(170)
|
(159)
|
(185)
|
(191)
|
(209)
|
(219)
|
(242)
|
(238)
|
(247)
|
(246)
|
(233)
|
(229)
|
(210)
|
(214)
|
(273)
|
(278)
|
(288)
|
(285)
|
(226)
|
(240)
|
(246)
|
(260)
|
(277)
|
(297)
|
(291)
|
(276)
|
(241)
|
(245)
|
|
Selling, General & Administrative |
(101)
|
(107)
|
(116)
|
(103)
|
(161)
|
(164)
|
(173)
|
(123)
|
(157)
|
(165)
|
(166)
|
(134)
|
(167)
|
(168)
|
(156)
|
(131)
|
(165)
|
(158)
|
(166)
|
(186)
|
(161)
|
(167)
|
(173)
|
(158)
|
(173)
|
(165)
|
(168)
|
(201)
|
(237)
|
(256)
|
(252)
|
(152)
|
(189)
|
(192)
|
(203)
|
(199)
|
(234)
|
(228)
|
(217)
|
(159)
|
(195)
|
|
Research & Development |
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
(9)
|
(37)
|
0
|
0
|
(22)
|
(34)
|
(34)
|
(45)
|
(49)
|
(42)
|
(47)
|
(48)
|
(43)
|
(33)
|
(37)
|
(31)
|
(31)
|
(28)
|
(33)
|
(34)
|
(37)
|
(30)
|
(34)
|
(35)
|
(32)
|
(31)
|
(37)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(35)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
(54)
|
0
|
|
Other Operating Expenses |
(3)
|
(7)
|
(9)
|
(0)
|
(11)
|
(8)
|
(11)
|
(1)
|
(11)
|
(16)
|
(19)
|
(0)
|
(10)
|
(1)
|
6
|
6
|
(26)
|
(51)
|
(31)
|
5
|
(43)
|
(34)
|
(25)
|
2
|
(9)
|
3
|
(3)
|
1
|
(5)
|
(1)
|
(1)
|
3
|
(19)
|
(20)
|
(20)
|
3
|
(29)
|
(28)
|
(28)
|
3
|
(13)
|
|
Operating Income |
109
N/A
|
106
-3%
|
100
-6%
|
171
+71%
|
178
+4%
|
198
+11%
|
212
+7%
|
213
+0%
|
216
+1%
|
188
-13%
|
160
-15%
|
102
-36%
|
98
-4%
|
110
+12%
|
121
+10%
|
132
+9%
|
131
-1%
|
125
-5%
|
131
+5%
|
81
-39%
|
56
-31%
|
38
-33%
|
10
-72%
|
42
+307%
|
14
-67%
|
21
+51%
|
40
+89%
|
(18)
N/A
|
6
N/A
|
0
-94%
|
4
+913%
|
69
+1 818%
|
55
-20%
|
57
+4%
|
39
-31%
|
21
-47%
|
(21)
N/A
|
(30)
-41%
|
(33)
-9%
|
23
N/A
|
(3)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
2
|
(4)
|
(8)
|
(9)
|
(9)
|
(15)
|
(15)
|
(14)
|
(14)
|
(12)
|
(9)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(3)
|
0
|
(3)
|
0
|
(2)
|
(5)
|
3
|
0
|
9
|
13
|
10
|
12
|
11
|
13
|
17
|
21
|
17
|
18
|
17
|
16
|
16
|
14
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
(0)
|
(5)
|
(0)
|
(0)
|
0
|
(9)
|
(1)
|
(1)
|
(1)
|
1
|
(1)
|
0
|
0
|
(19)
|
2
|
0
|
0
|
(63)
|
0
|
0
|
(0)
|
(15)
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
|
Total Other Income |
3
|
4
|
3
|
6
|
6
|
11
|
13
|
11
|
10
|
6
|
9
|
12
|
14
|
10
|
7
|
2
|
0
|
3
|
1
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
(7)
|
(8)
|
(7)
|
(6)
|
1
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
(33)
|
(33)
|
(34)
|
1
|
1
|
|
Pre-Tax Income |
114
N/A
|
107
-7%
|
95
-11%
|
168
+78%
|
175
+4%
|
194
+11%
|
210
+8%
|
209
0%
|
212
+1%
|
182
-14%
|
160
-12%
|
108
-32%
|
106
-2%
|
113
+7%
|
122
+8%
|
119
-2%
|
125
+5%
|
121
-3%
|
128
+5%
|
73
-43%
|
56
-23%
|
33
-41%
|
9
-72%
|
32
+246%
|
6
-80%
|
16
+149%
|
31
+96%
|
(15)
N/A
|
12
N/A
|
11
-7%
|
16
+40%
|
59
+270%
|
68
+16%
|
73
+7%
|
59
-19%
|
(25)
N/A
|
(36)
-42%
|
(46)
-28%
|
(51)
-11%
|
25
N/A
|
12
-50%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(15)
|
(16)
|
(14)
|
(24)
|
(25)
|
(28)
|
(31)
|
(31)
|
(31)
|
(27)
|
(21)
|
(16)
|
(16)
|
(16)
|
(20)
|
(18)
|
(20)
|
(19)
|
(17)
|
(11)
|
(7)
|
(5)
|
(6)
|
(4)
|
(1)
|
(2)
|
(5)
|
(15)
|
(17)
|
(18)
|
(16)
|
(12)
|
(13)
|
(15)
|
(12)
|
(11)
|
(9)
|
(7)
|
(6)
|
(2)
|
(2)
|
|
Income from Continuing Operations |
99
|
91
|
80
|
144
|
150
|
167
|
179
|
178
|
181
|
156
|
139
|
92
|
90
|
97
|
103
|
101
|
105
|
102
|
110
|
62
|
48
|
28
|
4
|
28
|
5
|
14
|
26
|
(29)
|
(5)
|
(7)
|
0
|
47
|
55
|
58
|
47
|
(36)
|
(44)
|
(52)
|
(57)
|
23
|
11
|
|
Income to Minority Interest |
0
|
0
|
0
|
(15)
|
(19)
|
(34)
|
(38)
|
(21)
|
(21)
|
(12)
|
(13)
|
(22)
|
(22)
|
(22)
|
(24)
|
(28)
|
(30)
|
(31)
|
(32)
|
(22)
|
(20)
|
(18)
|
(13)
|
(22)
|
(20)
|
(22)
|
(25)
|
(22)
|
(24)
|
(25)
|
(27)
|
(25)
|
(27)
|
(25)
|
(19)
|
(20)
|
(16)
|
(11)
|
(10)
|
(7)
|
(6)
|
|
Net Income (Common) |
99
N/A
|
91
-8%
|
80
-12%
|
128
+60%
|
131
+2%
|
133
+2%
|
142
+6%
|
157
+11%
|
160
+2%
|
144
-10%
|
126
-13%
|
70
-45%
|
68
-2%
|
75
+10%
|
79
+5%
|
73
-7%
|
75
+2%
|
71
-5%
|
78
+10%
|
41
-48%
|
28
-31%
|
10
-64%
|
(10)
N/A
|
6
N/A
|
(15)
N/A
|
(8)
+48%
|
1
N/A
|
(51)
N/A
|
(29)
+43%
|
(31)
-8%
|
(27)
+14%
|
22
N/A
|
28
+26%
|
33
+16%
|
28
-15%
|
(56)
N/A
|
(60)
-7%
|
(64)
-6%
|
(67)
-5%
|
15
N/A
|
4
-72%
|
|
EPS (Diluted) |
0.25
N/A
|
0.23
-8%
|
0.21
-9%
|
0.33
+57%
|
0.34
+3%
|
0.35
+3%
|
0.36
+3%
|
0.39
+8%
|
0.38
-3%
|
0.33
-13%
|
0.29
-12%
|
0.17
-41%
|
0.16
-6%
|
0.18
+13%
|
0.19
+6%
|
0.17
-11%
|
0.18
+6%
|
0.17
-6%
|
0.18
+6%
|
0.09
-50%
|
0.06
-33%
|
0.02
-67%
|
-0.02
N/A
|
0.02
N/A
|
-0.03
N/A
|
-0.02
+33%
|
0
N/A
|
-0.12
N/A
|
-0.06
+50%
|
-0.06
N/A
|
-0.06
N/A
|
0.05
N/A
|
0.05
N/A
|
0.06
+20%
|
0.05
-17%
|
-0.1
N/A
|
-0.11
-10%
|
-0.12
-9%
|
-0.12
N/A
|
0.03
N/A
|
0.01
-67%
|